Skip to main content
LLY
NYSE Life Sciences

AstraZeneca's New Obesity Pill Shows 11.8% Weight Loss in Trial, Challenges Lilly's Market Dominance

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1,149
Mkt Cap
$1.082T
52W Low
$623.78
52W High
$1,182.73
52W Position info
84% above low
Off High info
2.9% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

LLY sits 84% above its 52-week low of $623.78.

Summary

AstraZeneca announced positive mid-stage trial results for its experimental oral obesity pill, elecoglipron, showing patients lost 10.5% of body weight at 26 weeks and 11.8% at 36 weeks. This development introduces a new potential competitor in the lucrative obesity market, where Eli Lilly is a dominant player with its recently FDA-approved Foundayo (12% weight loss) and Zepbound (20%+ weight loss). While elecoglipron's efficacy is comparable to Foundayo, it adds competitive pressure to Lilly's market share and pricing power. AstraZeneca plans to advance elecoglipron to late-stage trials.

At the time of this announcement, LLY was trading at $1,149.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.1T. The 52-week trading range was $623.78 to $1,182.73. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LLY - Latest Insights

LLY
Nov 06, 2026, 6:45 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,346.00
Real-time Price: $1,357.00 info
Change: +$11.00 (+0.82%) info
Market Cap: $1.274T info
LLY
Nov 04, 2026, 1:53 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1,416.54
Real-time Price: $1,357.00 info
Change: -$59.54 (-4%) info
Market Cap: $1.274T info
LLY
Oct 29, 2026, 3:21 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1,368.10
Real-time Price: $1,357.00 info
Change: -$11.10 (-0.81%) info
Market Cap: $1.274T info
LLY
Oct 29, 2026, 12:08 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $1,370.30
Real-time Price: $1,357.00 info
Change: -$13.30 (-0.97%) info
Market Cap: $1.274T info
LLY
Oct 29, 2026, 11:35 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1,363.50
Real-time Price: $1,357.00 info
Change: -$6.50 (-0.48%) info
Market Cap: $1.274T info